The European regulator recommends granting pediatric use marketing authorization for Bopediat to treat children with oedema and hypertension from chronic kidney disease.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-backs-orodispersible-furosemide-edema-children-2026a10009h7?src=rss
Author :
Publish date : 2026-03-27 16:42:00
Copyright for syndicated content belongs to the linked Source.
